"Dueling" analgesic ads are "distasteful and regrettable misuse of science" -- NDAC's Juhl.
This article was originally published in The Tan Sheet
Executive Summary
"DUELING" ANALGESIC ADS "DISTASTEFUL AND REGRETTABLE MISUSE OF SCIENCE" by "all of the parties involved," Nonprescription Drug Advisory Committee Chairman Randy Juhl, PhD, University of Pittsburgh, commented at a recent meeting on pharmaceutical outcomes research. Sponsored by the Center for Pharmaceutical Outcomes Research, the meeting was held March 31-April 2 at the University of North Carolina, Chapel Hill.